Announcement of TTY Biopharm's unaudited income information in April 2022
2022.5.12
Provided by: TTY BIOPHARM COMPANY LIMITED
| SEQ_NO | 1 | Date of announcement | 2022/05/12 | Time of announcement | 13:36:08 |
| Subject | Announcement of TTY Biopharm's unaudited income information in April 2022 | ||||
| Date of events | 2022/05/12 | To which item it meets | paragraph 53 | ||
| Statement | 1.Date of occurrence of the event:2022/05/12 2.Company name:TTY Biopharm Co., Ltd. 3.Relationship to the Company (please enter ”head office” or ”subsidiaries”):Head office 4.Reciprocal shareholding ratios:N/A 5.Cause of occurrence:TTY Biopharm posted a consolidated net sales of $372,304 thousands (expressed in NT dollars; unaudited), a consolidated operating profit of $107,669 thousands, and a consolidated income before tax of $120,969 thousands in April 2022; net income attributed to stockholders of the company was $97,122 thousands; EPS is $0.39. Year-to-date consolidated net sales was $1,409,421 thousands (in NT dollars; unaudited), a consolidated operating profit was $354,226 thousands and consolidated income before tax was $408,217 thousands until April 2022; year-to-date net income attributed to stockholders of the company was $324,630 thousands; EPS is $1.31. 6.Countermeasures:N/A 7.Any other matters that need to be specified: The numbers above are unaudited. In term of the final net sales and profits, quarterly financial reports audited by independent accountants will prevail. |
||||